1025
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
SPECIFIC PROPERTIES OF THE DRUG AMANTADINE AGAINST VIRUSES AND IN
PARKINSON'S DISEASE
Irgashev Ibodillo Ergashevich
Faculty of Medicine, International University of Asia, Uzbekistan
Anesthesiologist-resuscitator.
https://doi.org/10.5281/zenodo.14743088
Abstract. Long-term therapy of Parkinson's disease (PD) with dopaminergic agents is
naturally accompanied by the appearance of symptom fluctuations and dyskinesias, and these
complications are an extremely important factor that adversely affects the quality of life.
Keywords: Parkinson's disease, substantia nigra, levodopa therapy, NMDA receptors,
Amantadine sulfate (PK-Merz), striocortical connections, amantadine hydrochloride.
СПЕЦИФИЧЕСКИЕ СВОЙСТВА ПРЕПАРАТА АМАНТАДИН В ОТНОШЕНИИ
ВИРУСОВ И ПРИ БОЛЕЗНИ ПАРКИНСОНА
Аннотация. Длительная терапия болезни Паркинсона (БП) дофаминергическими
средствами закономерно сопровождается появлением флуктуаций симптоматики и
дискинезий, и эти осложнения являются крайне важным фактором, отрицательно
влияющим на качество жизни.
Ключевые слова: болезнь Паркинсона, черная субстанция, терапия леводопой,
NMDA-рецепторы, амантадина сульфат (ПК-Мерц), стриокортикальные связи,
амантадина гидрохлорид.
In 2017, it was 200 years since the famous English physician James Parkinson described
the disease that was later named after him [1]. However, despite such a significant history of
studying Parkinson's disease (PD), this disease remains a serious challenge for clinical and
fundamental neurology to this day. As is known, the leading motor manifestations of PD
(hypokinesia, muscle rigidity, resting tremor) are caused by the death of dopamine neurons in the
substantia nigra of the midbrain, degeneration of the nigrostriatal pathway and destabilization of
the functional network of subcortical nuclei. A decrease in the inhibitory effect of dopamine on
striatal neurons leads to a relative predominance of the activity of the cholinergic systems of the
brain. Of additional importance is the excitotoxic effect of excess concentrations of glutamate,
caused by the disintegration of striocortical connections due to damage to the dopaminergic
mesocortical pathway. While recognizing the successes achieved, it should be emphasized that in
the long term, the treatment of patients with PD is associated with a number of complex problems
that are still far from being resolved.
1026
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
Motor complications of long-term levodopa therapy are of significant importance in
assessing the course of PD and mark the onset of the advanced stage of the disease. In the
pathophysiological mechanisms of levodopa-induced dyskinesias, the key role is played by the
hyperactivity of glutamatergic receptors located on the medium spiny neurons of the striatum: in
dyskinesias, hyperphosphorylation of NMDA receptors is noted, which leads to an increase in
synaptic efficiency and activation of the corticostriatal glutamatergic pathway. It has been shown
that dyskinesias and fluctuations of symptoms significantly impede the motor activity of patients
and are among the leading factors that reduce the quality of life. In its chemical structure,
amantadine is a tricyclic aminoadamantane 1-aminoadamantane hydrochloride (1-
adamantylamine hydrochloride). It is a white or white with a slight yellowish tint crystalline
powder with a bitter taste. Amantadine also exhibits a number of other important properties:
■ increased dopamine synthesis in nigral neurons;
■ increased release of dopamine (and other monoamine) vesicles into the synaptic cleft and
blocking the reuptake of dopamine by presynaptic terminals;
■ increased sensitivity of dopaminergic receptors to the neurotransmitter;
■ mild anticholinergic effect.
Amantadine is generally well tolerated in patients of all ages, although it should be used
with caution after 70–75 years of age. Side effects are rare and may include swelling (usually of
the shins and feet), dry mouth, mottling of the skin, sleep disturbances, episodes of agitation, and
hallucinations. Today, two main forms of amantadine are known - amantadine hydrochloride and
amantadine sulfate. Amantadine sulfate (PK-Merz) is characterized by a more stable concentration
in the blood and the absence of any significant "peak dose" effect, so even with long-term use, it
has a stable, persistent antiparkinsonian effect. Another major advantage of amantadine sulfate
(PK-Merz) is the availability (in addition to the standard tablet form) of a liquid form for infusion
administration. The infusion form of PK-Merz is the first and currently the only antiparkinsonian
drug that can be used parenterally.
REFERENCES
1.
Irgashev, I. E., & Farmonov, X. A. (2021). Specificity of resuscitation and rehabilitation
procedures in patients with covid-19.
Central Asian Journal of Medical and Natural
Science
,
2
(1), 11-14.
2.
Irgashev, I. E. (2022). New Principles of Anticoagulant Therapy in Patients with Covid-
19.
Research Journal of Trauma and Disability Studies
,
1
(12), 15-19.
3.
Irgashev, I. E. (2023). Pathological Physiology of Heart Failure.
American Journal of
Pediatric Medicine and Health Sciences (2993-2149)
,
1
(8), 378-383.
1027
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
4.
Irgashev, I. (2024). COVID-19 INFEKSIYSINI YUQTIRGAN KASALXONADAN
TASHQARI
PNEVMONIYA
BILAN
KASALLANGAN
BEMORLARDA
DROPERIDOL NEYROLEPTIK VOSITASINI QO’LLANILISHI VA UNING DAVO
SAMARADORLIGIGA TA’SIRI.
Центральноазиатский журнал образования и
инноваций
,
3
(1), 12-18.
5.
Irgashev, I. E. (2022). COVID-19 BILAN KASALLANGAN BEMORLARDA
ANTIKAOGULYANT
TERAPIYANING
YANGICHA
TAMOILLARI.
BARQARORLIK VA YETAKCHI TADQIQOTLAR ONLAYN ILMIY
JURNALI
,
2
(12), 462-466.
6.
Ergashevich, I. I. (2024). GIPERTONIK KRIZ BILAN KECHAYOTGAN
GIPERTONIYA KASALLIGIDA, ASORATLAR YUZ BERISHINI OLDINI OLISHGA
QARATILGAN
SHOSHILINCH
TERAPIYA.
ОБРАЗОВАНИЕ
НАУКА
И
ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
40
(1), 55-61.
7.
Ergashevich,
I.
I.
(2024).
SPECIFIC
PROPERTIES
OF
LEVAMICOL
OINTMENT.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
40
(1), 48-53.
8.
Irgashev, I. E. (2023). RESPIRATORY DISTRESS SYNDROME. Horizon: Journal of
Humanity and Artificial Intelligence, 2 (5), 587–589.
9.
Ergashevich, I. I. (2024). OTKIR KORONAR SINDROM KUZATILAYOTGAN
BEMORLARDA ILK YORDAM KO’RSATISHNING USTUVOR TAMOILLARI
HAMDA UNING AHAMIYATI.
TADQIQOTLAR. UZ
,
34
(2), 152-159.
10.
Ergashevich, I. I. (2024). GIPERTONIYA KASALLIGIDA SHOSHILINCH YORDAM
KO’RSATISH.
AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI
,
3
(3), 148-153.
11.
Иргашев, И. Э. (2024). ПРИНЦИПЫ ПРИОРИТЕТА И ЕГО ЗНАЧЕНИЕ
ОКАЗАНИЯ ПЕРВОЙ ПОМОЩИ У БОЛЬНЫХ ОСТРЫМ КОРОНАРНЫМ
СИНДРОМОМ.
TADQIQOTLAR. UZ
,
34
(2), 177-184.
12.
Иргашев, И. Э. (2024). ДЕЙСТВИЕ ДРОПЕРИДОЛА У БОЛЬНЫХ
ВНЕГОСПИТАЛЬНОЙ
ПНЕВМОНИЕЙ,
ИНФИЦИРОВАННЫХ
КОРОНОВИРУСОМ.
TADQIQOTLAR. UZ
,
34
(2), 160-168.
13.
Иргашев, И. Э. (2024). ПРИНЦИПЫ ОКАЗАНИЯ ПЕРВОЙ ПОМОЩИ БОЛЬНЫМ
ГИПЕРТЕНИЧЕСКИМ КРИЗОМ.
TADQIQOTLAR. UZ
,
34
(2), 185-192.
14.
Иргашев, И. Э. (2024). СКОРАЯ ПОМОЩЬ ПРИ ГИПЕРТОНИЧЕСКОЙ
БОЛЕЗНИ.
TADQIQOTLAR. UZ
,
34
(2), 169-176
1028
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
15.
Усмонов, У. Р., & Иргашев, И. Э. (2020). Changes in the morphofunctional properties of
thymus and spleen under the influence of mites of different origins.
Новый день в
медицине
, (2), 242-244.
16.
Ergashevich, I. I., Bahronovich, B. F., & Qilichevna, A. M. (2024). ASTMATIK
STATUSDAN
BEMORLARNI
CHIQARISHNING
ZAMONAVIY
TAMOYILLARI.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
43
(8), 36-44.
17.
Ergashevich, I. I. (2024). BRONXIAL ASTMA KASALLIGINI DAVOLASHGA
ZAMONAVIY YONDASHUV.
SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL
SCIENCES
,
3
(4), 266-272.
18.
Иргашев, И. Э., & Ахмедова, М. К. (2024). СОВРЕМЕННЫЕ ПРИНЦИПЫ
ВЫВОДА ПАЦИЕНТОВ В АСТМАТИЧЕСКОМ СТАТУСЕ.
ОБРАЗОВАНИЕ
НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
43
(8), 28-35.
19.
Saodat, A., Vohid, A., Ravshan, N., & Shamshod, A. (2020). MRI study in patients with
idiopathic cokearthrosis of the hip joint.
International Journal of Psychosocial
Rehabilitation
,
24
(2), 410-415.
20.
Axmedov, S. J. (2023). EFFECTS OF THE DRUG MILDRONATE.
Innovative
Development in Educational Activities
,
2
(20), 40-59.
21.
Jamshidovich, A. S. (2023). ASCORBIC ACID: ITS ROLE IN IMMUNE SYSTEM,
CHRONIC INFLAMMATION DISEASES AND ON THE ANTIOXIDANT
EFFECTS.
EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE
,
3
(11),
57-60.
22.
Jamshidovich, A. S. (2023). THE ROLE OF THIOTRIAZOLINE IN THE
ORGANISM.
Ta'lim innovatsiyasi va integratsiyasi
,
9
(5), 152-155.
23.
Jamshidovich,
A.
S.
(2023).
HEPTRAL
IS
USED
IN
LIVER
DISEASES.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
35
(3),
76-78.
24.
Jamshidovich, A. S. (2023). EFFECT OF TIVORTIN ON CARDIOMYOCYTE CELLS
AND ITS ROLE IN MYOCARDIAL INFARCTION.
Gospodarka i Innowacje.
,
42
, 255-
257.
25.
Jamshidovich,
A.
S.
(2024).
NEUROPROTECTIVE
EFFECT
OF
CITICOLINE.
EUROPEAN
JOURNAL
OF
MODERN
MEDICINE
AND
PRACTICE
,
4
(1), 1-4.
26.
Jamshidovich, A. S. (2024). THE ROLE OF TRIMETAZIDINE IN ISCHEMIC
CARDIOMYOPATHY.
Journal of new century innovations
,
44
(2), 3-8.
1029
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
27.
Jamshidovich,
A.
S.
(2024).
ВСЕ
ЭФФЕКТЫ
ПРЕПАРАТА
ИМУДОН.
TADQIQOTLAR
,
31
(2), 39-43.
28.
Jamshidovich, A. S. (2024). SPECIFIC FEATURES OF THE EFFECT OF THE
HEPARIN DRUG.
TADQIQOTLAR
,
31
(2), 34-38.
29.
Jamshidovich, A. S. (2024). USE OF GLUCOCORTICOSTEROIDS IN PEDIATRIC
PRACTICE.
TADQIQOTLAR
,
31
(2), 29-33.
30.
Jamshidovich,
A.
S. (2024). РОЛЬ ИНТЕЛЛАНОВОГО СИРОПА И
ЦИАНОКОБАЛАМИНА В УЛУЧШЕНИИ ПАМЯТИ.
TADQIQOTLAR
,
31
(2), 44-48.
31.
Jamshidovich, A. S. (2024). TREATMENT OF POLYNEUROPATHY WITH
BERLITHION.
Ta'limning zamonaviy transformatsiyasi
,
4
(1), 201-209.
32.
Jamshidovich, A. S. (2024). USE OF ASCORIL IN BRONCHIAL ASTHMA.
Ta'limning
zamonaviy transformatsiyasi
,
4
(1), 191-200.
33.
Jamshidovich,
A.
S.
(2024).
THE
IMPORTANCE
OF
THE
DRUG
ARTOXAN.
Ta'limning zamonaviy transformatsiyasi
,
4
(1), 182-190.
34.
Jamshidovich, A. S. (2024). THE ROLE OF RENGALIN IN CHRONIC
BRONCHITIS.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(4), 116-123.
35.
Jamshidovich, A. S. (2024). THE ROLE OF ALMAGEL DRUG IN GASTRIC AND
DUODENAL WOUND DISEASE.
Ta'limning zamonaviy transformatsiyasi
,
4
(1), 173-
181.
36.
Jamshidovich, A. S. (2024). THE ROLE OF CODELAK BRONCHO SYRUP IN
CHILDREN'S PRACTICE.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(4), 109-115.
37.
Jamshidovich, A. S. (2024). THE AEVIT DRUG EFFECT.
ОБРАЗОВАНИЕ НАУКА И
ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(4), 124-132.
38.
Jamshidovich, A. S. (2024). THE IMPORTANCE OF ALCHEBA DRUG IN POST-
STROKE APHASIA.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(4), 132-138.
39.
Jamshidovich, A. S. (2024). THE ROLE OF HYALURON CHONDRO DRUG IN
OSTEOARTHROSIS.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(4), 139-145.
40.
Jamshidovich,
A.
S.
(2024).
EFFECT
OF
SIMETHICONE
DROP
IN
FLATULENCE.
Лучшие интеллектуальные исследования
,
14
(1), 95-101.
41.
Jamshidovich, A. S. (2024). BENEFITS OF BETADINE SOLUTION.
Лучшие
интеллектуальные исследования
,
14
(1), 116-122.
1030
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
42.
Jamshidovich, A. S. (2024). EFFECT INHALED GLUCOCORTICOIDS IN CHRONIC
OBSTRUCTIVE
PULMONARY
DISEASE
AND
BRONCHIAL
ASTHMA.
TADQIQOTLAR
,
31
(1), 171-180.
43.
Jamshidovich, A. S. (2024). USE OF VIGANTOL IN RICKETS.
Лучшие
интеллектуальные исследования
,
14
(1), 102-108.
44.
Jamshidovich, A. S. (2024). THE VITAPROST DRUG RESULTS.
Лучшие
интеллектуальные исследования
,
14
(1), 109-115.
45.
Jamshidovich, A. S. (2024). THE ROLE OF BISEPTOL DRUG IN URINARY TRACT
DISEASE.
Лучшие интеллектуальные исследования
,
14
(1), 89-94.
46.
Jamshidovich,
A.
S.
(2024).
PROPERTIES
OF
THE
DRUG
DORMIKIND.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(5), 88-92.
47.
Jamshidovich, A. S., & Komilovich, E. B. (2024). IMMUNOMODULATORY
FUNCTION OF DIBAZOL DRUG.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ
ИДЕИ В МИРЕ
,
38
(5), 83-87.
48.
Jamshidovich, A. S., & Komilovich, E. B. (2024). ADVANTAGES OF THE DRUG
HEPTRAL.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(5),
98-101.
49.
Эргашов, Б. К., & Ахмедов, Ш. Ж. (2024). ГИПЕРТОНИЧЕСКАЯ БОЛЕЗНЬ
ЭТИОЛОГИЯ.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(6), 59-69.
50.
Komilovich, E. B., & Jamshidovich, A. S. (2024). HYPERTENSION, CLASSIFICATION
AND PATHOGENESIS.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(6), 50-58.
51.
Komilovich, E. B., & Jamshidovich, A. S. (2024). YURAK ISHEMIYASI.
STENOKARDIYADA SHOSHILINCH TIBBIY YORDAM.
ОБРАЗОВАНИЕ НАУКА
И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(6), 12-20.
52.
Komilovich,
E.
B.,
&
Jamshidovich,
A.
S.
(2024).
HYPERTENSION
ETIOLOGY.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(6),
32-41.
53.
Komilovich, E. B., & Jamshidovich, A. S. (2024). CARDIAC ISCHEMIA. ANGINA
NURSING DIAGNOSIS AND CARE.
Journal of new century innovations
,
46
(1), 44-52.
54.
Jamshidovich, A. S. (2024). IMPORTANT INDICATIONS OF THE DRUG
WOBENZYM.
Journal of new century innovations
,
46
(1), 29-32.
1031
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
55.
Jamshidovich, A. S. (2024). THE RESULTS OF THE EFFECT OF THE DRUG
VALIDOL.
Journal of new century innovations
,
46
(1), 19-23.
56.
Jamshidovich, A. S. (2024). VIFERON USE IN CHILDREN.
Journal of new century
innovations
,
46
(1), 24-28.
57.
Jamshidovich,
A.
S.
(2024).
USE
OF
DUSPATALIN
(MEBEVERINE
HYDROCHLORIDE)
IN
GASTROINTESTINAL
DISEASES.
ОБРАЗОВАНИЕ
НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(5), 93-97.
58.
Jamshidovich, A. S. (2024). ЭФФЕКТЫ СИРОПА ДЕПАКИНА (ВАЛЬПРОЕВАЯ
КИСЛОТА).
Ta'lim innovatsiyasi va integratsiyasi
,
14
(2), 148-152.
59.
Jamshidovich, A. S., & Komilovich, E. B. (2024). THE IMPORTANCE OF THE DRUG
ALLOCHOL
FOR
CHRONIC
CHOLECYSTITIS.
Ta'lim
innovatsiyasi
va
integratsiyasi
,
14
(2), 133-137.
60.
Jamshidovich, A. S., & Komilovich, E. B. (2024). ВАЖНЫЕ СВОЙСТВА
ПРЕПАРАТА
ДЕ-НОЛ
(субцитрат
висмута).
Ta'lim
innovatsiyasi
va
integratsiyasi
,
14
(2), 143-147.
61.
Jamshidovich, A. S., & Komilovich, E. B. (2024). SPECIAL FEATURES OF
BUDECTON DRUG.
Ta'lim innovatsiyasi va integratsiyasi
,
14
(2), 138-142.
62.
Jamshidovich, A. S. (2024). ЭФФЕКТИВНОЕ ВОЗДЕЙСТВИЕ ПРЕПАРАТА
КЕЙВЕР.
Ta'lim innovatsiyasi va integratsiyasi
,
15
(3), 137-143.
63.
Jamshidovich, A. S. (2024). USEFUL PROPERTIES OF THE DRUG YODOFOL.
Ta'lim
innovatsiyasi va integratsiyasi
,
15
(3), 144-149.
64.
Jamshidovich, A. S. (2024). FITOTERAPIYANING AKUSHER-GINEKOLOGIYADA
AHAMIYATI.
Лучшие интеллектуальные исследования
,
15
(2), 121-125.
65.
Jamshidovich, A. S. (2024). THE IMPORTANCE OF THE DRUG DOPROKIN.
Лучшие
интеллектуальные исследования
,
15
(2), 109-114.
66.
Jamshidovich, A. S. (2024). THE EFFECT OF DOSTINEX ON THE BODY.
Лучшие
интеллектуальные исследования
,
15
(2), 115-120.
67.
Jamshidovich, A. S. (2024). РЕЗУЛЬТАТЫ ЭФФЕКТИВНОГО ДЕЙСТВИЯ
ПРЕПАРАТА КАНЕФРОН.
Лучшие интеллектуальные исследования
,
15
(2), 138-
143.
68.
Jamshidovich, A. S. (2024). СОВРЕМЕННЫЕ ЭФФЕКТЫ ПРЕПАРАТА
ИНДОЛ.
Лучшие интеллектуальные исследования
,
15
(2), 126-131.
69.
Jamshidovich, A. S. (2024). EFFECT OF ISMIZHEN DRUG ON BODY
IMMUNITY.
Лучшие интеллектуальные исследования
,
15
(2), 132-137.
1032
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
70.
Jamshidovich, A. S. (2024). POSITIVE EFFECTS OF THE DRUG CARCIL.
Ta'lim
innovatsiyasi va integratsiyasi
,
15
(3), 127-131.
71.
Jamshidovich, A. S. (2024). PЕЗУЛЬТАТЫ ЭФФЕКТИВНОГО ДЕЙСТВИЯ
KАВИНТОНА.
Ta'lim innovatsiyasi va integratsiyasi
,
15
(3), 132-136.
72.
Jamshidovich, A. S. (2024). Современный Эффект Спрея Мометазон.
Research Journal
of Trauma and Disability Studies
,
3
(3), 62-65.
73.
Jamshidovich, A. S. (2024). THE ROLE OF" SIMONTE PLUS" DRUG IN THE
MODERN TREATMENT OF BRONCHIAL ASTHMA.
EUROPEAN JOURNAL OF
MODERN MEDICINE AND PRACTICE
,
4
(5), 66-70.
74.
Jamshidovich, A. S. (2024). FEATURES OF THE BIOMECHANISM OF THE DRUG
LEVOMYCETIN (CHLORAMPHENICOL).
EUROPEAN JOURNAL OF MODERN
MEDICINE AND PRACTICE
,
4
(9), 298-301.
75.
Jamshidovich, A. S. (2024). THE MOST IMPORTANT INDICATORS OF OMEGA 3
SUBSTANCE IN THE METABOLISM OF THE HUMAN BODY.
EUROPEAN
JOURNAL OF MODERN MEDICINE AND PRACTICE
,
4
(10), 113-117.
76.
Komilovich, E. B., & Khalimovich, M. N. (2024). CARDIAC ISCHEMIA. ANGINA
CLINICAL FORMS AND DIAGNOSIS.
Journal of new century innovations
,
46
(1), 70-
78.
77.
Komilovich, E. B. (2024). CORONARY HEART DISEASE. ANGINA EMERGENCY
CARE.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(7), 235-
242.
78.
Komilovich, E. B. (2024). YURAK ISHEMIK KASALLIGI. STENOKARDIYANI
DAVOLASHNING ZAMONAVIY TAMOYILLARI.
ОБРАЗОВАНИЕ НАУКА И
ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(6), 3-11.
79.
Komilovich, E. B., & Khalimovich, M. N. (2024). DEPENDENCIES IN THE CLINIC
AND DIAGNOSIS OF CORONARY HEART DISEASE AND ARTERIAL
HYPERTENSION.
Journal of new century innovations
,
46
(1), 61-69.
80.
Komilovich, E. B., & Xalimovich, M. N. (2024). YURAK ISHEMIYASIDA
HAMSHIRALIK DIAGNOSTIKASI VA PARVARISHI.
Journal of new century
innovations
,
46
(1), 79-85.
81.
Komilovich, E. B., & Khalimovich, M. N. (2024). NURSING CARE FOR CORONARY
ARTERY DISEASE, ANGINA PECTORIS.
Journal of new century innovations
,
46
(1),
86-94.
1033
ResearchBib IF - 11.01, ISSN: 3030-3753, Valume 2 Issue 1
82.
Jamshidovich, A. S. (2024). THE MOST IMPORTANT BENEFITS OF GINGER FOR
THE HUMAN BODY'S IMMUNITY.
EUROPEAN JOURNAL OF MODERN
MEDICINE AND PRACTICE
,
4
(11), 269-273.
83.
Axmedov, S. (2024). THE SPECIFIC EFFECT OF THE DRUG" BAKLASAN" IN
CEREBROVASCULAR DISEASES AND ITS PRACTICAL SIGNIFICANCE
TODAY.
Modern Science and Research
,
3
(12), 485-492.
84.
Axmedov, S. (2025). ВАЖНЫЕ СВОЙСТВА ПРЕПАРАТА ЭСКУЗАН ПРИ
СОСУДИСТЫХ ЗАБОЛЕВАНИЯХ.
Modern Science and Research
,
4
(1), 380-387.
85.
Xusenovich, M. S., & Turаpjаnovnа, Z. M. (2024). SEMIZLIKNING TURLI
FENOTIPLARDA
KARDIOMETABOLIK
XAVF
OMILLARINI
TAQQOSLASH.
SO‘NGI ILMIY TADQIQOTLAR NAZARIYASI
,
7
(4), 112-116.
86.
Husenovich, M. S., & Turabdjanovna, Z. M. (2024). STUDY OF DIURNAL PROFILE
OF
ARTERIAL
HYPERTENSION
IN
DIFFERENT
PHENOTYPE
OBESITY.
образование наука и инновационные идеи в мире
,
43
(1), 129-131.
87.
Xusenovich, M. S. (2024, September).
SEMIZLIKNI TURLI FENOTIPLARIDA YURAK
QON-TOMIR KASALLIKLARINI KELIB CHIQISH XAVFI PROGNOZI. In
INTERNATIONAL
SCIENTIFIC RESEARCH CONFERENCE
(Vol. 3, No. 26, pp. 15-18).
88.
Xusenovich, M. S. (2024). O ‘ZBEKISTONDA RESPUBLIKASIDA YURAK-QON
TOMIR
KASALLIKLARI
TARQALISHI
VA
HOZIRGI
KUNDAGI
KO’RILAYOTGAN CHORA TADBIRLAR.
AMERICAN JOURNAL OF SOCIAL
SCIENCE
,
2
(3), 79-82.
89.
Xusenovich, M. S., & Allayarovich, A. A. (2024). O ‘ZBEKISTONDA YURAK-QON
TOMIR
KASALLIKLARI
TARQALISHI
VA
HOZIRGI
KUNDAGI
TENDENSIYASI.
MODELS AND METHODS FOR INCREASING THE EFFICIENCY
OF INNOVATIVE RESEARCH
,
4
(38), 54-57.
90.
Ravshanovna, X. L. (2021, June). MINIMALLY INVASIVE METHODS OF
TREATMENT OF DENTAL CARIES IN ADULTS. In
" ONLINE-CONFERENCES"
PLATFORM
(pp. 118-119).
